Goserelin Included in Latest NCCN Breast Cancer Guidelines
The NCCN Breast Cancer Panel has included goserelin at 2 dosing schedules as a method for ovarian function suppression in their updated guidelines.
United States Mays Cancer Center Tersera Therapeutics National Comprehensive Cancer Network Breast Cancer Panel Division Of Hematology
Source: onclive.com